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INTRODUCTION 
   Pancytopenia is an important clinico-haematological entity 
encountered in our day to day clinical practice. There are varying trends in its 
clinical presentation, treatment approaches and outcome. It is a disorder where 
all the three major formed elements of blood namely the RBCs, WBCs and 
platelets are diminished in number. It is not a disease entity, but a triad of 
findings that may result from a wide number of possible disease processes — 
that primarily or secondarily involve the bone marrow. The severity of 
pancytopenia and the underlying pathology plays an important role in 
determining the treatment approach and response of patient to same. In India, 
the causes of pancytopenia are not well defined and the present study has been 
undertaken to evaluate the various causes and to correlate their peripheral blood 
findings and various haematological parameters to arrive at a specific diagnosis. 
I hope this data will help in planning the diagnostic and therapeutic approach in 
patients with pancytopenia.  
 
REVIEW OF LITERATURE 
  Pancytopenia is not an uncommon haematological problem which we 
face in our daily clinical practice and should be suspected whenever a patient 
presents with prolonged fever, unexplained anemia, and bleeding tendencies.  
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  It is defined as a reduction in all the three types of blood cell lines and 
thus involves anaemia, leucopenia and thrombocytopenia. It presents with 
symptoms of bone marrow failure such as pallor, dyspnoea, bleeding, easy 
bruising and increased propensity for infection. The causes for this condition are 
many and varied as seen in the study done by Khan et al
 
and includes 
megaloblastic anaemia, aplastic anaemia, myelodysplasia etc... The incidence of 
various disorders causing pancytopenia varies with varying geographical 
distribution and genetic disturbances. 
    
  The management and prognosis of pancytopenia depends on the 
underlying pathology as seen in study by Keisu M, Osta et al
18
. It can either be 
due to insufficient production of haematopoeitic cells in the bone marrow (as in 
infections, infiltration by malignant cells or due to effect of toxins) due to 
ineffective erythropoeisis with a normocellular or hypercellular marrow, without 
any abnormal cells, (eg- ineffective erythropoeisis and dysplasia), due to arrest 
in the maturation of cells or due to peripheral sequestration of blood cells. 
               
  Bone marrow biopsy plays an important role in the understanding of 
etiology of pancytopenia in patients who need laboratory workup. Commonly it 
is done for the evaluation of unexplained cytopenias and malignant conditions 
like leukemia. Bone marrow biopsy is done at times for diagnosis and staging of 
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neoplasm and storage disorders. Trephine biopsy is usually performed when 
there is hypoplasia or aplasia on aspiration. 
 
  In study by Kar M etal
16
 the commonest cause of pancytopenia was 
hypoplastic bone marrow followed by haematological malignancies and 
megaloblastic anemia.    
 
  In a study by Memon S et al
10
, common clinical presentations were 
pallor, fever, petechial hemorrhages, organomegaly and epistaxis and 
gastrointestinal tract bleeding. Infections were the third most common cause of 
pancytopenia in a study conducted by Gupta et al.
 
  
 
  In a study by Talarmin et al
19
 vitamin deficiencies were frequent in 
underdeveloped countries and were responsible for megaloblastic anaemia. The 
most common findings in the bone marrow evaluation were histiocytic 
haemophagocytosis and granulomas in a study by   Sari I et al.
21 
 
  In a study by Santra G et al, idiopathic aplastic anaemia (20.72 %) 
was the commonest cause of pancytopenia, followed by hypersplenism due to 
chronic liver disease (11.71 %). Combined cobalamin and folate deficiency was 
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seen in 5 patients (3.51%). Cobalamin deficiency was found to be more common 
in our setting and is largely underdiagnosed in the age of folate supplementation. 
  
  Chronic aplastic anaemia  may be one among the most common 
causes of bicytopenia or pancytopaenia during pregnancy, followed by 
myelodysplastic syndrome as seen in a study by Zhang C, Liang MY and Wang 
SM
.20
 
 
Causes of Pancytopenia
 
 
  They can be classified either into Primary and Secondary, Or 
according to cellularity of bone marrow as cellular or hypocellular marrow. 
 
 Primary                                                 Secondary 
                                                                 Nutritional  
  Idiopathic                                               Drugs 
  Congenital/ Familial                              Viral infections 
                                                                 Mycobacterial infections 
                   Autoimmune disorders 
                                                                 Chemicals (benzene, arsenic) 
                                                                 Cytotoxic drugs 
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                                                                 Malignant infiltration 
                                                                 Paroxysmal nocturnal haemoglobinuria 
 
Pancytopenia with Cellular Bone Marrow 
Primary bone marrow diseases                            Secondary to systemic diseases 
 Myelodysplasia                                                   SLE 
 Paroxysmal nocturnal haemoglobinuria             Hypersplenism 
 Myelofibrosis                                                      B12, Folate deficiency 
Some aleukemic leukemia                                    Overwhelming infection 
 Alcohol                                                               Tuberculosis 
 Myelophthisis                                                     Brucellosis 
 Bone marrow lymphoma                                     Sarcoidosis 
 Hairy cell leukemia                                              Leishmaniasis 
  
Pancytopenia with Hypocellular Bone Marrow 
Constitutional Aplastic Anemia (Fanconi‘s anemia, dyskeratosis congenita) 
Acquired Aplasic Anemia 
13 
 
Some acute lymphoid leukemia 
Rare aleukemic leukemia 
Some myelodysplasia 
Some lymphomas of bone marrow 
 
Hypocellular Bone marrow with or without Cytopenia 
Anorexia nervosa, starvation 
Mycobacterium 
Legionnaires‘ disease 
Q Fever 
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AIMS AND OBJECTIVES 
 
A) To study the various clinical presentations in pancytopenia. 
B) To evaluate various hematological parameters and to arrive at a diagnosis  
16 
 
MATERIALS AND METHODS 
 
Patients admitted in General Medicine Department of Government Medical 
College, Tirunelveli fulfilling criteria for pancytopenia were evaluated 
clinically. Adequate haematological investigations and other relevant 
investigations were carried out. Peripheral smear and bone marrow examination 
were done if necessary and other investigations were also carried out as a part of 
the workup. 
 
STUDY DESIGN 
Cross sectional observational study 
 
SAMPLE SIZE 
All cases of pancytopenia in patients admitted in Medicine Department wer 
evaluated. 
 
STUDY PERIOD 
JULY2014- JUNE2015 
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INCLUSION CRITERIA 
 
Case selection was based on clinical features and supported by laboratory 
evidence, which included peripheral blood counts for haemoglobin, WBCs and 
platelets. Inclusion criteria were presence of all 3 of the following: 
 
Haemoglobin  <10gm/dl 
Total WBC count  <4,000 / μL 
Platelet count  <1,00,000/ μL 
 
 
EXCLUSION CRITERIA 
 
Patients on chemotherapy 
Patients below 13 years of age 
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Haematopoiesis
2,4 
  Haematopoiesis is a complicated process by which haematopoietic 
stem cells can both self replicate to maintain a pool of hematopoietic stem cells 
and also differentiate into myeloid and lymphoid lineage committed 
hematopoietic progenitor cells, which can further terminally differentiate to 
produce all the cellular elements of blood. 
  It is believed that haematopoiesis begins as early as 3
rd
 week after 
fertilisation, both from aorto-gonadal-mesonephros region and from extra-
embryonic mesoderm in yolk sac. This is followed by shift of site of 
erythropoeisis to the fetal liver and spleen, and fetal liver remains the dominant 
hematopoietic site in fetal life. By the 5
th
 month of gestation, haematopoiesis 
gets established in bone marrow. At the time of birth, haematopoietic red bone 
marrow is found in the medullary cavities of every bone, but as age advances 
they get replaced by fat/yellow marrow and at adulthood red marrow gets 
restricted to pelvis, vertebrae, clavicles, ribs, sternum, skull, proximal humeri 
and upper femora. 
 
Bone Marrow
2 
  Bone marrow is one of the largest organs in the human body 
approaching size and weight of liver. Normally, WBC producing myeloid series 
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of cells constitute 75% of cells, while maturing RBCs constitute 25%. This 
difference is due to difference in lifespan of both RBCs and WBCs. 
 
  Haematopoietic stem cells are bone marrow cells that are derived 
from uncommitted totipotent stem cells, which can form any cell in the body 
which includes all types of blood cells which can differentiate into a particular 
type of committed stemcells(progenitor cells) which in turn form various 
differentiated types of blood cells. There are separate pools of progenitor cells 
for RBCs, megakaryocytes, lymphocytes, eosinophils and basophils; but 
neutrophils and monocytes arise from a common precursor cell. Bone marrow 
stem cells also form the source of osteoclasts, mast cells, dendritic cells, Kupffer 
cells and Langerhans cells. 
 
Normal Bone Marrow Structure
4 
  The red marrow is interspersed between the trabeculae of bone within 
the bony cavity. It contains special connective tissue cells, reticulin, blood 
vessels, fat, nerves and macrophages in addition to cells of the lymphoid and 
haemopoietic series. A supportive framework is provided by a network of fine 
reticulin fibrils. These fibrils are produced by the adventitial reticular cells. 
Arteriolar blood passes into the relatively large lumen of sinusoids which are 
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lined by a single layer of endothelial cells. Entry of newly formed blood cells 
into the circulation occurs at this site. Fat cells contribute to approximately half 
the extra vascular volume of red marrow and nearly all of the extravascular 
volume of yellow marrow in the peripheral parts of the long bones. 
 
Ratio 
  The M: E ratio is based on a count of 200 to 500 marrow cells. In a 
normal adult the ratio is about 3:1 or 4:1 
 
Spleen
1 
  It forms part of reticuloendothelial system which develops during 5
th
 
week of gestation in the dorsal mesogastrium. 
Physiological role 
- Maintenance of quality of RBCs by removing senescent & defective ones 
- Production of antibodies in white pulp 
- Removal of antibody coated bacteria & blood cells 
Adaptive functions of spleen
1 
- Clearance of bacteria and particulate materials from blood 
- Immune response generation to pathogens 
- Extramedullary hematopoiesis at times of need 
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Normal human spleen contains significant number of marginated neutrophils 
and 1/3
rd
 of total body platelets and these sequestrated cells are available when 
body needs them during bleeding or infection. 
 
Various Cytokines and the cell lines they stimulate
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Cytokine Stimulated cell line Source 
Erythropoietin Erythrocyte Kidney and Kupffer cell in liver 
SCF Erythrocyte, 
Granulocyte, 
Monocyte, 
Megakaryocyte 
Multiple cell types 
G-CSF Granulocyte Fibroblasts, Monocytes, 
Endothelial cells, 
GM-CSF Erythrocyte, 
Granulocyte, 
Megakaryocyte 
Fibroblasts, Endothelial cells, T 
lymphocytes, Monocytes, 
M-CSF Monocyte Fibroblasts, Endothelial cells, 
Monocytes 
Thrombopoietin Megakaryocyte Kidney, liver 
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IL-1 Erythrocyte, 
Granulocyte, 
Monocyte, 
Megakaryocyte 
Multiple cell types 
IL-3 Erythrocyte, 
Granulocyte, 
Monocyte, 
Megakaryocyte, 
T lymphocytes 
IL-4 Basophil T lymphocytes 
IL-5 Eosinophil T lymhocytes 
Il-6 Erythrocyte, 
Granulocyte, 
Monocyte, 
Megakaryocyte, 
Endothelial cells, fibroblasts, 
macrophages 
IL-7 B cells Leukocytes 
IL-8 T cells and neutrophils Leukocytes 
IL-9 BFU-E, CFU-GEMM Lymphocytes 
 
IL-11 
Erythrocyte, 
granulocyte, 
megakaryocyte 
Fibroblasts, osteoblasts 
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ERYTHROPOEISIS
4 
 
Stages of development 
 .CFU-E 
· Proerythroblast(least mature form, prominent nucleoli) 
· Basophilic erythroblast(maximum ribosomes, chromatin condensation) 
· Polychromatic erythroblast(maximum mitochondria) 
· Orthochromatic erythroblast_ lose their nucleus 
· Reticulocye( Nucleus absent) 
· Mature erythrocyte/RBC 
 
GRANULOPOIESIS
4 
 
NEUTROPHIL SERIES 
 
Stages of development 
· Myeloblast (round or oval nucleus with fine chromatin& 1-5 nucleoli) 
· Promyelocyte (largest cell with less prominent nucleoli) 
· Myelocyte (nuclear indentation & coarse chromatin structure, last cell that is 
capable of cell division) 
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· Metamyelocyte ( bean shaped nucleus) 
· Band or stab form 
· Segmented or polymorphonuclear granulocyte 
· Polymorphonuclear eosinophil (bilobed nucleus, basophilic cytoplasm filled 
with orange red granules) 
· Polymorphonucelar Basophil (deeply staining blue to purple metachromatic 
granules obscuring nucleus & cytoplasm stains reddish pink)  
 
THE MONOCYTE – MACROPHAGE SERIES4 
 
Monoblast (round or oval nucleus with fine chromatin) 
Promonocyte (indented nucleus with single nucleoli) 
Monocyte (large, lobulated or bean shaped nucleus without nucleoli) 
Macrophage (mobile & phagocytic)  
 
THE LYMPHOID SERIES
4 
 
Lymphoblast 
Large lymphocyte 
Small lymphocyte 
Plasma cell 
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THE MEGAKARYOCYTIC SERIES
4 
 
Megakaryoblast 
Promegakaryoctye 
Megakaryoctye 
Platelet 
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MACROCYTIC ANEMIA 
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HYPERSEGMENTED NEUTROPHILS 
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PERIPHERAL BLOOD PICTURE OF 
ACUTE MYELOID LEUKEMIA 
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BONE MARROW PICTURE OF ACUTE 
MYELOID LEUKEMIA 
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TEAR DROP CELLS 
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BONE MARROW PICTURE IN 
MYELOFIBROSIS 
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BONE MARROW PICTURE IN APLASTIC 
ANEMIA 
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Major Functions of Blood Cells
4 
RBCs- Delivers oxygen to tissues from lungs and carbon dioxide back from 
tissues to lungs 
WBCs- 
Neutrophils- Recognise, ingest and destroy foreign particles & microbes 
Eosinophils-  Phagocytic, involved in intracellular killing of protozoa and 
helminths, also involved in allergic reaction 
Basophils- Involved in hypersensitivity reactions 
Monocytes- Migrates into tissue where they become macrophages, antigen 
presenting dendritic cells or Kupffer cells and helps in removing 
microorganisms, apoptotic cells and debris 
Lymphocytes- Mediate cellular and humoral immunity 
Platelets- Aggregate at site of tissue damage and forms a plug to arrest 
hemorrage 
 
HYPERSPLENISM
1 
  It is a well known fact that certain patients with splenomegaly due to 
various diseases develop neutropenia, anemia or thrombocytopenia, and that 
splenectomy results in improvement of the peripheral blood picture, even back 
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to normal though usually reversal of granulocytopenia is not sustained. This 
fact, that the peripheral blood picture may be corrected by splenectomy, led to 
the concept of hypersplenism. 
 
Clinical Features 
  The initial clinical picture varies widely. Manifestations depend on the 
severity of the anemia, thrombocytopenia or leucopenia. Sometimes 
splenomegaly is detected as an incidental feature in a patient, who has presented 
with symptoms of a disorder that is capable of diminishing the levels of all the 
cellular elements of blood. 
  The clinical features and simple laboratory findings reflect the 
underlying disease process. Thus, the presence of splenomegaly calls attention 
to the possibility of leukemia, myelofibrosis or a congestive cause for 
splenomegaly. The presence of enlarged lymph nodes supports the possibilities 
of leukemia, one of the lymphomas, or SLE. The presence of rouleaux formation 
in the bloodsmear or Bence Jones protein in the urine suggests myeloma. 
Immature erythrocytes and leukocytes in the blood smear (leukoerythroblastic 
blood picture) should lead the clinician to consider infiltrative disease of bone 
marrow (for example, metastatic carcinoma, leukemia or myelofibrosis). The 
anemia in disorders with pancytopenia is usually normochromic and normocytic, 
but occasionally it is mildly macrocytic. 
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Etiology 
 
Primary (idiopathic) 
 
Secondary: 
 Portal hypertension with congestive splenomegaly 
 Lymphomas 
 CLL 
 Hairy cell leukaemia 
 Infections like Tuberculosis, malaria, kala azar 
 
Mechanism of hypersplenism
1 
  The process involved in lowering of RBC count, is the pooling of red 
cells within the enlarged spleen.  Cytopenia results from greater destruction of 
cellular elements caused by decreased flow of blood through enlarged and 
congested cords or due to immune related mechanisms.  Radionucleotide studies 
indicate that passive pooling of red blood cells within the spleen has a greater 
impact in lowering of red cell count in the blood rather than the accelerated 
destruction of entrapped red cells. 
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Diagnostic criteria for hypersplenism 
 
1. Anemia, leucopenia, thrombocytopenia, either singly or in combination 
2. Cellular or hyperplastic bone marrow picture 
3. Splenomegaly 
4. Marked improvement following splenectomy in peripheral smear 
 
Blood picture 
 Anaemia is usually normocytic and normochromic although they may be 
spherocytic due to longer transit in enlarged spleen causing loss of surface area. 
 Leukopenia is primarily due to accompanying neutropenia, but in severe 
cases all white cells get reduced.  
 Moderate thrombocytopenia can occur with a platelet count of about    100 
X 10
9
/L, but occasionally values can drop upto 50 X10
9
/L. 
 
Bone marrow
1,4 
  Bone marrow either shows normal or increased cellularity or may 
show infiltration by disease process that is responsible for splenic enlargement. 
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Megaloblastic anaemia
1,2 
 
PATHOGENESIS OF MEGALOBLASTIC ANAEMIA 
  Megaloblastic anaemia occurs due to abnormal maturation of 
hematopoietic cells caused by impaired DNA synthesis. Cobalamine (vitamin 
B12) and folic acid are two essential vitamins required for DNA biosynthesis. 
Deficiency of either of them results in what is known as nucleo-cytoplasmic 
asynchrony. All actively dividing cells will exhibit megaloblastosis; hence 
changes are evident in the cells of small intestine, buccal mucosa, tongue, 
uterus, cervix and vagina. In the haematopoietic system this asynchrony results 
in normal cytoplasmic maturation along with abnormal nuclear maturation 
resulting in apoptosis, intra-medullary haemolysis, ineffective erythropoeisis, 
pancytopenia and typical morphological abnormalities in the bone marrow and 
peripheral smear which are mentioned later. 
 
Causes of Folic acid deficiency
2 
 
Nutritional deficiency 
 Substance abuse, Alcoholism, Poor dietary intake, Overcooked foods 
Malabsorption 
 Celiac disease, Infiltrative bowel disease, Inflammatory bowel disease, Short 
bowel syndrome 
40 
 
Drugs 
 Trimethoprim, Methotrexate, Alcohol, Phenytoin 
Increased requirements 
 Pregnancy, Lactation, Exfoliative dermatitis, Chronic haemolysis 
 
Causes of Vitamin B12 Deficiency
2 
 
Gastric abnormalities 
 Including atrophic gastritis leading to malabsorption of cobalamin, Zollinger 
– Ellison syndrome, gastric bypass surgeries 
Intestinal causes 
 Includes pancreatitis, radiotherapy, HIV infection, gluten induced 
enteropathy, Graft versus host disease etc.. 
Pernicious anemia 
Autoimmune metaplastic atrophic gastritis 
Malabsorption syndrome 
Small bowel disease 
Blind loops 
Ileal resection or bypass 
Crohn's disease 
Pancreatitis 
Pancreatic insufficiency 
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Diet 
  Strict vegetarians 
  Vegetarian diet during pregnancy 
Agents that can affect absorption 
  Colchicine 
  PAS 
  Neomycin 
  Biguanides 
  Anticonvulsants 
  Proton pump inhibitors 
  Cytotoxic drugs 
  N2O anesthesia 
  Alcohol 
 
Clinical Manifestations of Cobalamin Deficiency
2 
 
  The classic picture of Cobalamine deficiency due to pernicious 
anemia was that of a prematurely graying, mentally sluggish person with a shiny 
tongue (atrophic glossitis) and a shuffling broad gait. This classic picture of 
pernicious anemia is now seen less frequently. It has been replaced by more 
subtle presentations. Because Cobalmine is required for all rapidly growing cells 
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including enteric mucosal cells and epithelial cells of the skin, patients with 
Cobalamine deficiency may complain of glossitis, vaginal atrophy, and 
malabsorption; they often have diffuse hyper-pigmentation particularly 
increased pigmentation over knuckles. The patient may have neuro-psychiatric 
problems consisting of paraesthesiae, numbness, weakness, impaired memory 
and personality changes. Examination reveals haematologic and neurologic 
abnormalities. When the anaemia is severe, there may also be 
thrombocytopaenia and neutropaenia (i.e. pancytopenia). Thrombocytopenia 
occasionally may be associated with frank mucosal bleeding. 
 
Neurologic Abnormalities
1 
  The neurologic abnormalities when they occur, presents with subacute 
paresthesias in upper and lower limbs with loss of position and vibration sense 
and a progressive spastic and ataxic weakness. Presence of Babinski sign with 
absent reflexes caused by peripheral neuropathy is classical of this condition. 
This classical picture of subacute combined degeneration of spinal cord is 
specific for vitamin B12 deficiency, and is caused by defect in myelin formation 
due to unknown mechanisms. The myelopathy is symmetrical and tends to be 
diffuse affecting legs more than the arms with associated spasticity, clonus, 
paraplegia and even faecal and urinary incontinence. Other neurologic 
abnormalities seen include loss of memory, optic atrophy, mental changes and 
dementia. 
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Clinical Manifestations of folic acid deficiency
2 
 
  The haematologic manifestations of folate deficiency are similar to 
those of Cobalamine deficiency but neurologic abnormalities do not occur. 
Another important difference is the time required for deficiency to develop. 
Because Cobalamine stores are so large in body in relation to daily intake, a year 
of inadequate intake or absorption is required before the development of 
symptoms. On the other hand, symptoms of folate deficiency can occur within a 
few weeks after intake is diminished. Folate deficiency occurs in patient who 
abuse alcohol or other drugs and have a very poor dietary intake. Older and 
depressed patients who live alone and avoid cooking foods that contain folate 
may become deficient, as can patients with malabsorption syndrome. Increased 
folate demands occur in patients with chronic severe haemolytic anaemia and 
pregnancy. 
 
Hyperhomocysteinaemia 
  Both Cobalamine and Folic acid are required for metabolism of 
homocysteine to methionine. As a result, deficiencies in these vitamins can lead 
to increase in plasma homocysteine levels, which can then lead onto the 
development of atherosclerosis and venous thrombosis. 
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DIAGNOSIS OF MEGALOBLASTIC ANAEMIA
2,9 
   
  The evaluation of suspected Cobalamine or folate deficiency generally 
proceeds through two stages: Documentation of the presence of the vitamin 
deficiency and then determination of its cause (e.g. malabsorption, dietary 
deficiency or Pernicious anemia). The diagnosis of deficiency can most often be 
established by a combination of the following; mean corpuscular volume (MCV) 
of RBCs, peripheral blood smear evaluation and bone marrow studies; 
measurement of the serum B12 and the red blood cell (or serum) folate 
concentrations and evaluation of specific metabolites (e.g. methylmalonic acid 
and homocysteine). 
  An elevation in MCV of erythrocytes is one of the hallmarks of B12 
and folate deficiency. The degree of elevation of the MCV is often a clue to the 
presence of vitamin deficiency. The major haematologic finding is a macro-
ovalocytic anaemia (with increased serum bilirubin and LDH levels that reflect 
the increased RBC breakdown due to inefficient erythropoiesis). The absolute 
reticulocyte count is normal or even distinctly low. The peripheral blood smear 
shows macroovalocytes, occasionally megaloblasts and hyper-segmented 
neutrophils (forming more than 5% of neutrophils) with 5 or more lobes or 1% 
with 6 or more lobes. Hypersegmentation is the result of an alteration of late 
granulopoiesis. When the anaemia is severe, there may also be associated 
thrombocytopaenia and neutropaenia (i.e. pancytopaenia). Bone marrow 
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aspiration and biopsy reveal a hypercellular marrow with giant metamyelocytes 
and megaloblastic erythroid hyperplasia. 
 
Confirming the diagnosis 
  If serum folate and cobalamin concentrations are >4 ng/ml and >300 
pg/mL respectively, deficiencies of the two vitamins are quite unlikely. If the 
above two tests are not within range, the next step is evaluation of the 
metabolites, methylmalonate (MMA) and total homocysteine. If test results are 
within the normal range for both, deficiency of both these vitamins can be ruled 
out. 
 
Treatment
1 
Folic acid deficiency — Standard dosing of oral folic acid is 1 to 5 mg orally 
daily for about  four months or until complete haematologic recovery occurs. 
Vitamin B12 deficiency must be ruled out, and treated if present, before giving 
folic acid to a patient, since administration of folic acid alone can lead on to 
worsening of neurologic complications of untreated vitamin B12 deficiency. 
 
Cobalamine deficiency — For patients with permanently impaired ability to 
absorb vitamin B12 from food (eg- pernicious anemia, total gastrectomy), life-
long treatment is necessary. Intially parenteral vitamin B12 is preferred over oral 
therapy. Maintenance therapy with oral therapy is also possible. 
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Aplastic Anaemia
3, 23 
 
  Aplastic anaemia (AA) is defined by the presence of pancytopaenia 
with hypocellular marrow in which normal haemopoietic marrow is replaced by 
fat cells. It shows a biphasic distribution with two peaks, one in the age group of 
15-25 and the other peak after 60 years. It is a life-threatening disorder, which if 
left untreated, is associated with a very high mortality rate. A rare disorder 
which is characterized by diminished or absent hematopoietic precursors in the 
bone marrow chiefly due to failure of pluripotent stem cells resulting in 
hypoplasia of bone marrow and pancytopenia. Stem cell failure can be 
congenital (eg- Fanconi‘s anemia) or more often acquired. Bone marrow failure 
usually occurs due to severe damage to hematopoietic cell compartment. The 
cells which bear the CD34 antigen, a marker of early hematopoietic cell, are 
greatly decreased. 
 
Causes
14 
Congenital 
Fanconi anemia — There are numerous causes for congenital aplastic anemia. 
The most common is Fanconi‘s anemia,a familial condition characterized by 
pancytopenia, macrocytic anemia and congenital malformations. 
Dyskeratosis Congenita 
Shwachman- Diamond Syndrome 
47 
 
Acquired 
 
Cytotoxic drugs and radiation 
Drugs 
Anticonvulsants 
 Carbamazepine 
 Phenacemide 
 Hydantoins 
Immunosuppresives 
 Azathioprine 
Antibiotics 
 Sulfonamides 
 Chloramphenicol 
Antirheumatics 
 Phenylbutazone, 
 Indomethacin 
 Gold 
 Penicillamine 
Anti-Thyroid Medications 
 Methimazole 
 Propylthiouracil 
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Toxic chemicals 
 Benzene toluene solvents 
 Glue vapors 
Insecticides 
 DDT 
 Organophosphorous compounds 
 Organocarbamates 
Viral infections 
 Epstein-Barr virus 
 Seronegative hepatitis 
 Human immunodeficiency virus 
 Other herpes viruses 
Immune disorders 
 Eosinophilic fasciitis 
 Systemic lupus erythematosus 
 Graft versus host disease 
Miscellaneous 
 Radiation 
 Thymoma 
 Pregnancy 
 Anorexia nervosa 
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Clinical features
11 
  They usually present with easy fatigability and cardiopulmonary 
complications. There may be recurrent infections due to neutropenia, and 
bleeding can occur following development of thrombocytopenia. Bacterial, viral 
and fungal infections can occur following aplasia. Pallor and petechiae are the 
usual clinical manifestations. Hepatomegaly and splenomegaly usually does not 
accompany. 
 
Diagnosis 
 Peripheral blood picture will show pancytopenia, low reticulocyte count and 
often macrocytosis.  
 Bone marrow examination will reveal hypocellular marrow with a decrease 
in all the elements; the marrow space will be composed mainly of fat cells and 
marrow stroma. Residual hematopoietic cells will be morphologically normal 
and hematopoiesis will not be megaloblastic. 
 
Treatment
1 
  It invoves blood product support and control of infection. If the age of 
patient is less than 30 years, allogenic bone marrow transplantation may be 
considered where they have 75-90% long term cure chance. In elderly use of 
immunosuppressives like ciclosporin and antithymocyte globulin gives a 5 year 
survival of 75%. 
50 
 
Multiple Myeloma
1,3 
  It is characterised by neoplastic proliferation of immunoglobulin-
secreting plasma cells of a single clone. Most patients present with organ 
dysfunction, symptoms or signs related to the infiltration of plasmacells into the 
bone or other organs thereby resulting in bony pain or fractures, kidney damage, 
anemia, hypercalcemia, neurological symptoms, hyperviscosity manifestations 
and clotting abnormalities from excess light chains. 
 
Clinical features 
  Back ache is the most prevalent symptom in myeloma which is seen 
in about 70% of patients. This is followed by susceptibility to infections, most 
common being infections of lung and renal tissue. Most common pathogens 
implicated are Staphylococcus aureus, Streptococcus pneumonia and Klebsiella 
pneumoniae in lungs and Escherichia coli in genitourinary tract.  Anemia, renal 
failure or proteinuria, fatigue, and hypercalcemia are other common 
manifestations. Less common presentations include spinal cord compression, 
deep vein thrombosis and polyneuropathies. 
 
Specific investigations 
  Classic triad
3
 of multiple myeloma is lytic bone lesions, marrow 
plasmacytosis(>10%) and a serum and/or urine M component. 
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 Blood and urinary protein electrophoresis 
 Blood and urine immunoelectrophoresis 
 Bone marrow aspiration and trephine 
 Plasma immunoglobulins 
 Serum light chain assay 
 MRI spine 
 Serum beta 2 microglobulin (provide an idea regarding prognosis) 
Diagnostic Criteria( all 3 must be met) 
 Presence of 10% or more clonal bone marrow plasma cells or a biopsy 
proven plasmacytoma 
 Presence of  M-protein in serum and/or urine 
 Presence of a related organ or tissue impairment that can be attributed to  
plasma cell proliferative disorder (anemia, renal insufficiency, increased serum 
calcium and lytic bone lesions) 
Differential Diagnosis 
 Monoclonal Gammopathy Of Undetermined Significance (MGUS) 
 AL Amyloidosis 
 Smoldering Multiple Myeloma (SMM) 
 Solitary Plasmacytoma 
 Waldenstrom Macroglobulinemia 
 POEMS Syndrome 
 Metastatic Carcinoma. 
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  Presence of paraproteins in blood will cause background basophilic 
staining and increased clustering of RBCs (rouleaux formation). Lytic bone 
lesions may be seen in any of the bones. The following distribution was found in 
a large case series study with vertebral column affected in 66%, ribs in 44% 
cases, skull in 41%, followed by pelvis, femur, clavicle and scapula. 
 
Management
1 
  
Asymptomatic- No treatment 
Analgesics for bony pains 
High fluid intake 
Bisphosphonates for hypercalcemia 
Allopurinol to prevent urate nephropathy 
Plasmapheresis for hyperviscosity 
In transplant candidates- Newer agents like bortezomib or lenalidomide 
combined with pulsed glucocorticoids 
Non transplant candidates- intermittent pulses of an alkylating agent like 
melphalan with prednisone. 
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PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
1 
 
  Lewis and Dacie, in 1967, suggested that ―PNH represents a somatic 
mutation in the hematopoietic stem cell which was already damaged during an 
aplastic episode‖. Triad in PNH include hemolysis, pancytopenia and tendency 
for venous thrombosis. Patient seeks doctor‘s advice following passage of blood 
instead of urine. Some others present with recurrent attacks of abdominal pain. 
When thrombosis occurs in hepatic veins it cause hepatomegaly with ascites 
which may be suspected as PNH in the absence of liver disease. An acquired 
mutation in the PIG-A gene of haematopoietic stem cells, results in a clone of 
progeny without glycosylphosphatidylinositol-linked cell surface membrane 
proteins
22
. PNH cells are detected by expression of CD55 or CD59 on 
granulocytes detected by flow cytometry
23
. Definitive diagnosis of PNH must be 
made on demonstration of RBCs showing increased susceptibility to 
compliment C due to deficiency of CD 59 and CD55, proteins that protect RBCs 
from activated C. Gold standard is flow cytometry while other tests used are 
sucrose hemolysis test and Ham test. Thrombosis is one among the life 
threatening complications of PNH. 
Treatment of PNH includes supportive therapies like transfusion, iron and folic 
acid supplementation, IV eculizumab every 14 days. Definitive cure is 
accomplished by allogenic bone marrow transplantation. 
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MYELODYSPLASIA
1, 23 
 
They are a heterogeneous group of haematologic disorders characterised by 
cytopenias with a dysmorphic and usually cellular bone marrow resulting in 
ineffective blood cell production. 
 
WHO Classification  
 
Refractory cytopenias with unilineage dysplasia 
Refractory anemia with ringed sideroblasts 
Refractory cytopenias with multilineage dysplasia 
Refractory anemia with excess of blasts 
MDS associated with isolated Del(5q) 
Childhood MDS 
Unclassifiable MDS  
 
Epidemiology 
Idiopathic MDS is a disease of the old age with a mean age of onset after 70 
years and a slightly increased male incidence. 
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Etiology and pathophysiology 
 
  They are frequently linked to environment exposures to radiation and 
benzene. Secondary myelodysplastic syndromes occur as a late toxicity to 
cancer therapy. Impaired cell proliferation and differentiation can occur with 
MDS. Cytogenetic abnormalities are found in almost half the number of patients 
with MDS. 
Pathophysiology – They result from multiple genetic lesions, loss of tumour 
suppressor genes, activation of oncogene or their mutations, inefficient 
erythropoiesis and deranged iron metabolism are some of the usual functional 
consequences of the genetic alterations in myelodysplasia. 
 
Clinical features 
 
  Anaemia is the predominant feature in the early course. Most patients 
present with complaints of gradual onset of fatigue, weakness, dyspnoea and 
pallor, but at least half of the patients are asymptomatic and MDS is discovered 
only incidentally on routine examination of blood. The physical examination is 
remarkable for signs of anemia with about 20% of patients having 
splenomegaly. Some unusual skin lesions like febrile neutrophilic dermatosis 
(Sweet‘s syndrome) have been linked with myelodysplasia. 
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Laboratory studies 
Blood 
Anaemia is present in the most of the cases, either alone or a part of 
pancytopenias. Presence of macrocytes in peripheral smear is common and the 
smear may be dimorphic in nature. Thrombocytes are large and are 
hypogranulated. Neutrophils may have hyposegmented, ringed or abnormally 
segmented nuclei. Amount of circulating myeloblasts usually correlate with 
number of blasts in marrow and is important in classification and prognosis. 
Bone marrow 
Marrow is usually normal or hypercellular, but in few (20%) cases it may be 
sufficiently hypocellular to get confused with aplasia. There is no single 
characteristic feature of marrow morphology that distinguishes myelodysplasia 
from other causes. Dyserythropoietic changes and ringed sideroblasts in the 
erythroid lineage; hypogranulation and decreased segmentation of granulocytic 
precursors, with an increase in number of myeloblasts; and megakaryocytes 
showing decreased numbers of disorganized nuclei are some of them. 
Treatment 
  Only stem cell transplantation offers cure. However, multiple new 
drugs have been approved for use in MDS.  Supportive care described for 
aplastic anemia applies to myelodysplasia
23
. Despite improvements in drug 
therapy, patients will be anemic for many years and blood transfusion should be 
administered along with iron chelation to prevent secondary haemochromatosis. 
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Myelofibrosis
1,2 
 
  Primary myelofibrosis (PMF), previously called chronic idiopathic 
myelofibrosis (CIMF) also called as agnogenic myeloid metaplasia
12
, is one 
among the chronic myeloproliferative disorders which is characterized by 
proliferation of myeloid cells with variable morphologic maturity, bone marrow 
fibrosis, leukoerythroblastic blood picture and extramedullary haematopoiesis. 
Acute myelofibrosis has been applied to clinical picture seen in AML M7. 
 
EPIDEMIOLOGY 
 Least frequent among the chronic myeloproliferative disorders. 
  Occurs mainly in middleaged and elderly. 
 
CLINICAL PRESENTATION 
 
  Most patients present after 50 years of age with weight loss, fatigue 
and night sweats among which the most common presenting symptom is fatigue. 
Hepatomegaly and massive spleenomegaly can occur due to extra medullary 
haematopoesis associated with primary myelofibrosis along with painful splenic 
infarcts. 
  Splenomegaly, often marked, is the hallmark of primary 
myelofibrosis. Palpable hepatomegaly is present in 40 to 70% of patients. Portal 
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hypertension may develop as a result of increased splanchnic blood flow due to 
splenomegaly and/or intrahepatic obstruction associated with extramedullary 
hematopoiesis. 
Other sites of extramedullary haematopoeisis 
· Lymph nodes 
· Vertebral column (especially thoracic vertebrae) 
· Genitourinary system 
· Retroperitoneum 
· Lungs and pleural cavity 
 
Osteosclerosis of bone may occur following primary myelofibrosis 
.Radiographic appearance of mottling may be seen in primary myelofibrosis. 
 
LAB FINDINGS
12 
Anaemia 
- Autoimmune hemolysis  
- Ineffective erythropoiesis associated with extramedullary sites of RBC 
production 
- Decrease in medullary erythropoietic sites 
- Sequestration of RBCs in the spleen and destruction of circulating RBCs 
- Bleeding caused by thrombocytopenia or other complications like varices 
resulting from portal vein thrombosis 
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- Influence of thrombopoietin receptor (Mpl) mutations  
Thrombocytosis or thrombocytopenia can occur. Leucocytosis or leucopenia can 
occur.  
Bone marrow aspiration will give a dry tap. If there is any aspirate, that will 
show neutrophilic and megakaryocytic hyperplasia. Bone marrow biopsy is 
necessary to demonstrate fibrosis. 
 
Diagnosis of PMF should be entertained only if all of the following features are 
present at the time of initial detection 
- Nucleated RBCs in peripheral blood 
- Tear drop RBCs in peripheral blood 
- Premature WBCs in the peripheral blood 
- Splenomegaly 
 
2008 WHO criteria include a combination of following findings 
24 
o Presence of megakaryocyte proliferation and atypia, usually accompanied by 
reticulin 
o WHO criteria for Polycythemia Vera, Chronic Myeloid Leukemia, 
Myelodysplastic Syndrome  or other myeloid neoplasms are not satisfied 
o Demonstration of clonal markers ( JAK2 or MPL) 
o Leukoerythroblastosis 
o Palpable spleen 
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o Anemia 
o Increased serum LDH levels 
Median survival is 4 years from the time of diagnosis and the treatment is 
directed at the control of symptoms like transfusion for anemia. Folic acid 
should be supplemented to avoid deficiency.  Hydroxycarbamide is used to 
control splenic size, WBC count and systemic features. Splenectomy may be 
contemplated if the spleen is grossly enlarged or symptomatic pancytopenia 
secondary to hypersplenism develops. Bone marrow transplantation may be tried 
in young individuals. 
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Metastatic carcinoma 
Patients with carcinoma usually have anemia, with or without associated 
cytopenias.  
 
1. Direct toxicity of malignancy 
Acute leukemias can directly cause suppression of normal erythropoiesis in 
marrow, thus resulting in anemia due to marrow failure. As in myelodysplasia, 
anemia caused by acute leukemia is frequently macrocytic and have a reduced 
reticulocyte count. 
 
     2.  Indirectly resulting from malignancy 
Autoimmune hemolytic anemia are seen in patients with chronic lymphocytic 
leukemia whereas microangiopathic hemolytic anemia is commonly seen in 
gastric cancer which also occurs in carcinomas invoving breast and lungs. 
Another common form of anemia seen in cancer patients is anemia of chronic 
disease. Here the marrow is normocellular, with a normal myeloid erythroid 
ratio and an increase in amount of storage iron in histiocytes. 
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RESULTS 
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RESULTS 
 
 
 
 
SEX DISTRIBUTION 
 
SEX COUNT PERCENTAGE 
MALE 22 37% 
FEMALE 38 63% 
 
Females formed majority of patients accounting for 63% while men were only 
33% of the patients who presented with pancytopenia. 
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AGE DISTRIBUTION 
AGE 
RANGE MALE FEMALE 
PERCENTAGE 
13-30 9 20 48.33% 
31-50 7 10 28.33% 
51-70 5 7 20% 
>70 1 1 3.33% 
TOTAL 22 38 100% 
 
 
In this study, majority of patients belonged to the age range of 13-30 accounting 
for 48.33% followed by middle aged people in the 31-50 age range accounting 
for 28.33% of the studied population. 
Average age of patients was found to be 38 with a standard deviation of 18.30. 
Oldest was an 86 year old male and youngest was a 13 year old boy. 
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CHIEF PRESENTING COMPLAINTS 
TYPE COUNT PERCENTAGE 
Fever 38 63.33% 
Mucosal Bleeding 19 31.67% 
Fatiguability 24 40% 
Shortness of Breath 31 51.67% 
Cough 14 23.33% 
Dependent Oedema 25 41.67% 
Abdominal Pain 21 35% 
Petechiae/Purpura 2 3.33% 
Chest Pain 6 10% 
 
Chief presenting complaint among those presented with pancytopenia was fever 
(63.33%) followed by breathlessness (51.67%) and dependant oedema 
(41.67%). 
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ADDICTION PATTERN 
ADDICTED TO NO OF PATIENTS PERCENTAGE 
None 47 78.33% 
Smoking 7 11.67% 
Alcoholism 3 5% 
Both 3 5% 
 
 
About 78% of studied population were free from addiction to either smoking or 
alcohol consumption. Among those who had a risk behaviour smoking was 
prevailing(11.67%) with 5% of total study group having both smoking and 
alcohol consumption as a risk factor. 
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85% of pancytopenia patients were found to be nonvegetarians while rest 15% 
were found to be vegetarians. 
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GENERAL EXAMINATION  
 NO. OF PATIENTS PERCENTAGE 
Pallor 57 95% 
Icterus 20 33.33% 
Lymphadenopathy 3 5% 
Oedema 30 50% 
 
 
95% of patients who had pancytopenia were appreciated to have clinically 
significant pallor while 50% had pedal oedema. 33% had clinical evidence of 
jaundice while 5% had generalised lymphadenopathy. 
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Abdominal Findings 
 No of Patients PERCENTAGE 
Hepatomegaly 6 10% 
Splenomegaly 12 20% 
Hepatosplenomegaly 7 11.67% 
No Organomegaly 35 58.33% 
 
 
 
About 32% of pancytopenia patients had splenic enlargement, 22% had 
hepatomegaly while 12% had combined hepatosplenomegaly. 
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Haemoglobin in Gram % No. of Patients Percentage 
<4 17 28.33% 
4-7 27 45% 
>7 16 26.67% 
 
 
45% of patients were found to have moderate anemia, 28.33% had severe 
anemia and 26.67% had minimal anemia. Average haemoglobin of study 
population was 5.74+/-2.17. Highest haemoglobin recorded was 9.9gm% while 
lowest was found to be 2.3gm%. 
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RBC COUNT 
IN MILLIONS/mm
3 
NO. OF PATIENTS PERCENTAGE 
<2 30 50% 
2-4 25 41.67% 
4-5.5 5 8.33% 
 
 
Mean RBC count was found to be 2.16 million/mm
3 
with a standard deviation of 
0.93 million/mm
3
. Majority of patients having RBC count less than 2million 
cells/mm
3
 and 92% had RBC count less than 4 million cells/mm
3
. 
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Total WBC Count 
CELLS/mm
3
 NO. OF PATIENTS PERCENTAGE 
<1000 2 3.33% 
1000-3000 44 73.33% 
>3000 14 23.33% 
 
 
 
73% patients presented with total WBC count between 1000 and 3000 
cells/mm
3
, while 2 patients (3.33%) had a very low WBC count of 
<1000cells/mm
3
. Average WBC count was found to be 2432+/- 799 cells/mm
3. 
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DIFFERENTIAL COUNT 
TYPE NO. OF PATIENTS PERCENTAGE 
NORMAL 27 45% 
NEUTROPHILIA 13 21.67% 
LYMPHOCYTOSIS 20 33.33% 
 
 
45% of people had normal differential count while 22% had neutrophilia and 
33% had lymphocytosis in the study. 
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Platelet Count 
COUNT NO. OF PATIENTS PERCENTAGE 
<10000 7 11.67% 
10000-50000 31 51.67% 
>50000 22 36.67% 
 
 
31 patients had a platelet count between 10,000- 50,000cells/mm
3
, 22 patients 
had a platelet count of > 50,000cells/mm
3 
while 7 people presented with a very 
low platelet count of <10,000cells/mm
3 
Mean platelet count in the study population was found to be 40750 with a 
standard deviation of 24789. 
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MEAN CORPUSCULAR VOLUME 
 (IN FEMTO LITRES) NO. OF PATIENTS PERCENTAGE 
<80 21 35% 
80-95 21 35% 
>95 18 30% 
 
 
30% of people presented with macrocytic anemia while 35% presented with 
normocytic and microcytic anemia. Average MCV was found to be 87.53+/-
17.17 . 
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Mean Corpuscular Haemoglobin 
In Picogram/cell NO. OF PATIENTS PERCENTAGE 
<26.5 25 41.67% 
26.5-32 17 28.33% 
>32 18 30% 
 
 
Mean Corpuscular Hemoglobin was found to be 28.19pg/cell with a standard 
deviation of 6.68. 
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Mean Corpuscular Hemoglobin Concentration 
In gm/dL NO. OF PATIENTS PERCENTAGE 
<32 27 45% 
32-36 30 50% 
>36 3 5% 
 
Mean Corpuscular Hemoglobin Concentration was found to be almost equally 
distributed among <32gm/dL and those with 32-36gm/dL. 
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Erythrocyte Sedimentation Rate 
MM/ FIRST HR NO. OF PATIENTS PERCENTAGE 
<20 4 6.67% 
21-60 25 41.67% 
>60 31 51.67% 
 
 
Mean ESR was 65.53 with a standard deviation of 35.84. 
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RFT was found to be normal in 49 out of 60 patients (81.5%) with 18.5% having 
abnormal RFT. 
LFT was found to be abnormal in 33% of the study population. 
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PERIPHERAL SMEAR FINDINGS 
 NO. OF PATIENTS PERCENTAGE 
Microcytic 20 33.33% 
Macrocytic 8 13.33% 
Normocytic 5 8.33% 
Dimorphic 27 45% 
 
 
Dimorphic anemia was found to be the predominant peripheral blood picture 
seen in about 45% of patients. The next most common peripheral blood picture 
was microcytic anemia(33.33%) followed by macrocytic anemia and normocytic 
blood picture. 
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18 out of 60 patients had undergone bone marrow study. Aplastic anemia was 
found to be the most common peripheral blood picture followed by combined 
nutritional deficiency and myelofibrosis.  
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Ultrasound Study of Abdomen 
 NO. OF PATIENTS PERCENTAGE 
Splenomegaly 18 30% 
Hepatomegaly 5 8.33% 
Hepatosplenomegaly 4 6.67% 
Parenchymal Liver 
Disease 
7 11.67% 
Medico Renal Disease 2 3.33% 
Normal 24 40% 
 
 
In ultrasound study of abdomen, 40% had a normal sonogram, 36.67% had 
enlarged spleen, 8.33% had hepatomegaly. 
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Diagnosis 
 NO. OF PERSONS PERCENTAGE 
Hypersplenism/DCLD 14 23.33% 
Megaloblastic Anemia 10 16.67% 
Dimorphic Anemia 9 15% 
Infections/Sepsis 10 16.67% 
Others 17 28.33% 
 
 
Majority of cases of pancytopenia were found to be caused by hypersplenism 
with or without associated decompensated liver disease(23.33%), followed by 
megaloblastic anemia which accounted for 16.67% of cases. Other common 
causes for pancytopenia included sepsis/infections, dimorphic anemia, combined 
nutritional deficiencies, drug induced, aplastic anemia, myelofibrosis etc… 
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 No Of Patients Percentage 
Infections/Sepsis 8 33.33% 
Megaloblastic Anemia 5 20.83% 
Hypersplenism/DCLD 3 12.5% 
Others 8 33.33% 
 
In the age group of 13-30 years, infections/sepsis comprised maximum number 
of cases accounting for 33% of cases followed by megaloblastic anemia(21%). 
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 No of Patients Percentage 
Hypersplenism/DCLD 5 29% 
Dimorphic anemia 3 18% 
Megaloblastic anemia 3 18% 
Others 6 36% 
 
In the age group of 31-50 years hypersplenism accounted for maximum number 
of cases with 29% followed by megaloblastic and dimorphic anemias.  
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 No of Patients Percentage 
Hypersplenism 6 21% 
Dimorphic anemia 4 14% 
Others 19 65% 
 
 
In this age group, hypersplenism accounts for maximum number of cases 
followed by dimorphic anemia. 
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Out of 10 cases of megaloblastic anemia, 6 cases(60%) were females while 4 
cases(40%) comprised of males. 
 
 
Out of 9 megaloblastic anemia cases 4 practiced a nonvegetarian diet while 5 
people followed a vegetarian diet. 
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 No of Patients Percentage 
Megaloblastic Anemia 4 18% 
Infections 4 18% 
Hypersplenism/DCLD 3 14% 
Combined nutritional 
deficiency 
3 14% 
Others 8 36% 
 
In males, megaloblastic anemia and infections comprised majority of 
cases followed by decompensated liver disease and combined 
nutritional deficiency. 
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 No of Patients Percentage 
Hypersplenism/DCLD 11 29% 
Infections 6 16% 
Megaloblastic anemia 6 16% 
Others 15 39% 
 
Hypersplenism accounts for majority(29%) of patients in females followed by 
infections(16%) and megaloblastic anemia(16%).
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Out of 10 patients who had megaloblastic anemia, 6 people showed decreased 
levels of vitamin B12 in their blood.  
Others
4
40%
Vitamin B12 
Deficiency
6
60%
Cases of Vitamin B12 deficiency among 
Megaloblastic Anemia
Others
Vitamin B12 Deficiency
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DISCUSSION 
  Pancytopenia is a clinico-haematological entity encountered in our 
day to day practice in which all the three major formed elements of blood 
(RBCs, WBCs and platelets) are diminished in number. There are varying trends 
in its clinical pattern, treatment modalities, and outcome. 
  In this study around 60 cases of pancytopenia were studied. Various 
clinical and hematological parameters were evaluated and final diagnosis for 
pancytopenia was made. Clinical and haematological profile of patients with 
pancytopenia was studied, including their presenting symptoms and physical 
findings. Peripheral smear examination and ultrasound study findings were also 
evaluated in each case. 
  In the study out of 60 cases, 38 patients were females and 22 were 
males. Thus females formed the majority of patients, while in other studies done 
by Gayathri et al and Santra et al, showed a male predominance with male to 
female ratio of 1.2:1 and 1.47:1 respectively. Male to female ratio was 0.58:1 in 
this study group.  
  Patients were predominantly in the age group of 13-30 years 
(48.33%). Mean age was 38years in the study population. An Indian study 
published in May 2013 showed that majority (65%) of patients were in the age 
group of <40years. This study also showed male predominance with M:F ratio 
1.6:1. Another study conducted in Iraq in 2009 showed the mean age of 
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pancytopenia presentation being 38yrs and had slight male predominance (M:F 
= 1.2:1). In another study done by Hema et al from Bengaluru also showed male 
predominance (60%) with most of the patients in the age group of 21 - 30 years 
and females aged greater than 50 were affected more. Thus this study is in 
compliance with most of them in the age group but sex distribution is very much 
different from other studies. 
  Percentage of patients presented with following presenting complaints 
namely fever, fatiguability, oedema and bleeding were 63%, 40%, 42% and 32% 
respectively, whereas it was asthenia (100%) and fever (28%) the predominant 
symptoms in the study by Nafil H
7
. In the study done by B N Gayathri et al
8
 
most common presentation was generalized weakness; other major complaints 
were breathlessness, fever and loss of weight. Pallor was present in every case. 
In this study 95% patients were clinically having pallor,  icterus in 33%, oedema 
in 50%, splenomegaly in 32%, hepatomegaly in 22% and combined 
hepatosplenomegaly in 12%. 
  So the most common findings were pallor, oedema and splenomegaly. 
In a study by Sarode et al
5
, 46% had hepatomegaly, 34% had mild 
splenomegaly. In comparison the study by Gayathri et al
8
, the most prevalent 
physical finding was pallor (100%), followed by splenic enlargement (35.57%) 
and enlargement of liver (26.92%). 
  Haemoglobin values were distributed around 4-7 gm% in 45% of 
people, >7gm% in 27%. Mean haemoglobin was 5.74+2.17 (range- 2.3 to 9.9 
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gm%). While mean haemoglobin was 6.5 g/dL (range 2.9-9.2g/dL) in the study 
by Nafil H. Mean haemoglobin (Hb) was 5.6 +/- 1.7 g/dl in a study by Doshi D 
etal. In our study 73% of patients had leucocyte count in the range of 1001-
3000, 23% had leucocyte count above 3000 to 4000, 4% had leucocyte count 
below 1000. Mean leukocyte count was 2432 with a standard deviation of 800. 
Lowest WBC count recorded in the study was 600 and highest 3900. In the 
study by Nafil H
7
 , mean leucocyte count was around 2360/mm
3
 (range 840-
3360/mm
3
) while in the study by Doshi D etal
6
, mean white blood corpuscle 
(WBC) count was 2735 +/- 415/mm
3
. In our study patients with platelet count in 
the range 10000-50000 constituted 51.67% and 50000-100000 in 36.67% with a 
mean platelet count of 40750 and standard deviation of 24789. Lowest platelet 
count was recorded as 3000 and highest being 97000.  In the study by Doshi D 
etal
6
 mean platelet count was 52,250 +/- 24,213 and in the study by Nafil H
7
, 
mean platelet count 66 000/mm
3
 (range 3000-123000/mm
3
). In my study, 
51.67% of patients had ESR value above 60. Similarily in the study carried out 
by Gayathri etal
8
, ESR was elevated above 50 in around 78% of patients. 
  In our study, 18 patients were having MCV >95 out of which 10 had 
megaloblastic anaemia, out of which (6) 60% had serum B12 levels <200. So 
60% of patients with megaloblastic anemia had reduced Vitamin B12 assay. In 
the study by Doshi D et al
6
 mean MCV value was 101.2 +/- 11 in patients with 
megaloblastic anaemia. In a recent study, Sarode R et al
5
 have analysed 139 
consecutive cases of nutritional megaloblastic anaemia over a period of four and 
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a half years, vitamin B12 deficiency was detected in 76%, folate deficiency in 
6.8%, combined B12 and folate deficiency in 8.8%; the remaining 7.8% had 
normal vitamin levels at presentation. Percentage of patients with megaloblastic 
anaemia who were having significant vitamin B12 deficiency in my study was 
comparable to other studies. 
  In our study, 45% of patients had a dimorphic blood picture, 8% 
patients had normocytic normochromic blood picture, 33% had microcytic 
hypochromic blood picture and 13% had macrocytic blood picture. In the study 
by Gayathri etal
7
, the predominant blood picture was dimorphic anemia (37.5%), 
followed by macrocytic anemia (31.7%). 
  In our study, DCLD with associated hypersplenism(23.33%) was 
found to be the most common cause of pancytopenia followed by megaloblastic 
anemia.(16.67%). Other causes were dimorphic anemia, infections, aplastic 
anemia, combined nutritional deficiencies, myelofibrosis etc… In a study by 
Santra G
25
, aplastic anaemia (20.72 %) was the most common cause of 
pancytopenia followed by hypersplenism associated with chronic liver disease 
(11.71 %). Another study by Osama et al
26
, also had megaloblastic anaemia as 
the leading cause of pancytopenia.  
  In patients with aplastic anemia, hepatomegaly and splenomegaly 
were absent, oedema(66%) and icterus(33%) were the predominant findings. In 
megaloblastic anemia, oedema occured in 46%, and splenomegaly in 8% of 
patients. In my study, in 13-30 year age group, sepsis or infection comprised 
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most of cases accounting for 33% cases followed by megaloblastic anemia 21%.  
In 31-50 yrs age group as well as in 51-70 age group, chronic liver disease 
leading to hypersplenism was the most common cause of pancytopenia, 
followed by megaloblastic anemia.  
  When analyzing sex wise distribution of pancytopenia, cause of 
pancytopenia in males were megaloblastic anemia(18%) followed by infections 
and hypersplenism. In females the most common cause was found to be 
hypersplenism followed by infections and megaloblastic anemia. Females were 
having 1.5 times more prevalence of megaloblastic anemia compared to males. 
Totally there were 9 vegetarians, out of which 5 were having megaloblastic 
anaemia. Vegetarians are having more megaloblastic anemia predisposing to 
pancytopenia.  
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CONCLUSION 
In my study, it was seen that hypersplenism was the most common cause of 
pancytopenia. Similar to recent studies carried out by Osama et al
26
 and Gayatri 
et al
8
, megaloblastic anaemia has also emerged as a common cause of 
pancytopenia. Vegetarians are more predisposed to develop megaloblastic 
anaemia.  
 Hypersplenism was the most common cause of pancytopenia in my study 
 Young people contributed to the major bulk of pancytopenia cases. 
 Fever, breathlessness and dependant oedema were the predominant 
presentations 
 Pallor, oedema, splenomegaly and hepatomegaly were the predominant 
clinical findings 
 Dimorphic blood picture was predominantly seen in peripheral blood. 
 Vitamin B12 deficiency was found in about 60% of megaloblastic anemia. 
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LIMITATIONS 
 Only patients above 12 years of age were included in the study since 
Department of Medicine admits patients above 12 years of age only. 
 The sample size was small; hence definite statistical analysis to find out 
different causal factors was not feasible. 
 The period of study was only 1 year. Long term follow up study is also 
required to correctly establish the etiology. 
 Transient pancytopenia can occur following various infections. 
 Many patients are missed because only inpatients were included in the study. 
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SUGGESTIONS 
 
o A detailed follow up study to analyze the etiologies for pancytopenia for 
sufficiently long duration for better analysis and hypothesis. 
o A comparative study using healthy controls could be better to establish the 
relation of dietary deficiency with the etiologies other than nutritional anemia. 
o The issue why megaloblastic anemia is more common among females is to 
be studied in detail to bring out any social issues including gender 
discrimination. 
o Since megaloblastic anaemia with vitamin B12 deficiency is common, 
dietary habits should be modified. 
o Since pregnancy is an important cause for pancytopenia, a study involving 
them as study group with special emphasis on the precipitating factors should 
also be done. 
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ABBREVIATIONS 
PMF=Primary Myelofibrosis 
DCLD= Decompensated Chronic Liver Disease 
CKD=Chronic Kidney Disease 
MDS=Myelodysplastic Syndrome 
RBC= Red Blood Corpuscle 
WBC=White Blood Corpuscle 
SLE=Systemic Lupus Erythematosis 
TB= Tuberculosis 
Fl=Femtolitres 
Pg/ml=Pictogram/ml 
MCV=Mean Corpuscular Volume 
MCH=Mean Corpuscular Haemoglobin 
MCHC=Mean Corpuscular Hemoglobin Concentration 
HTN = Hypertension 
PCV=Packed Cell Volume 
ESR=Erythrocyte Sedimentation Rate 
RFT=Renal Function Test 
LFT= Liver Function Test 
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ANNEXURE 1 
PROFORMA 
SL no:      Contact no: 
 
Name:      IP No:  
 
Age:        Unit: 
 
Sex:       Date of Admission: 
 
Occupation:      Date of Discharge : 
 
History 
Fever  
Spontaneous mucosal bleeding  
Petechiae, purpura  
Fatigability  
Shortness of breath  
Chestpain  
Infections  
Lymphadenopathy  
Cough  
Dependent oedema  
Abdominal pain  
Weight loss  
Onset  
Drug intake  
 
Past history 
DM/HTN/TB/LIVER DISEASE/CANCER 
Family history :      TB/LIVER DISEASE/CANCER 
Personal History:    Smoker              alchoholic         Veg/non veg   
   Appetite             High risk behavior 
 
108 
 
General Examination 
• Pallor                                    :yes/no 
• Icterus                                   :yes/no 
• Cyanosis                               :yes/no 
• Clubbing                           :yes/no 
• Lymphadenopathy                :yes/no 
• Edema                            :yes/no 
Vitals 
• Blood pressure            : 
• Pulse rate             : 
• Respiratory rate               : 
 
 Examination 
     
Eye examination                                                Retinal haemorrhage  
Oral examination 
     Petechiae :              Gingival hyperplasia : 
     Stomatitis/cheilitis:         Oral candidiasis : 
Respiratory Examination 
     Clubbing 
Abdominal examination  Lymphadenopathy/  Hepatomegaly/ Splenomegaly  
Skin examination 
   Malar rash  
   Purpura /bruising 
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   Hyperpigmentation, café au lait , Skin nodules 
Musculoskeletal examination 
  Short Stature :     Abnormal thumbs:  
 
INVESTIGATIONS 
  Hemoglobin:   Red Blood Cell Count: 
  Total Leukocyte Count:  Differential Leukocyte Count: 
  Platelet Count: 
  Mean Corpuscular Volume (MCV) : 
  Mean Corpuscular Haemoglobin (MCH): 
  Mean Corpuscular Hemoglobin Concentration (MCHC): 
  Packed Cell Volume (PCV): 
  Erythrocyte Sedimentation Rate (ESR): 
  Peripheral Smear:  
 Bone Marrow Aspiration If Needed: 
 Chest  X Ray: 
 USG  Abdomen: 
 Renal Function Test: 
 Liver Function Test: 
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Fever
Mucosal 
Bleeding
Fatigu-
ability
Breath-
lessness
Cough
Dependen
t Oedema
Abdomina
l Pain
Petechiae
/Purpura
Chest 
Pain
Diabetes CKD
Hyper-
tension
TB CAHD
LIVER 
DISEASE
None Smoking Alcohol None
1 Arumugakani 40 F 6399 Y Y Y Y Y Non-Vegetarian
2 Kalaiselvi 26 F 7735 Y Y Y Y Y Non-Vegetarian
3 Ranganathan 68 M 7960 Y Y Y Y Y Y Non-Vegetarian
4 Annamalaiyammal 20 F 8908 Y Y Y Y Y Non-Vegetarian
5 Murikeshveri 22 F 8996 Y Y Y Y Y Vegetarian
6 Sudalaimuthu 68 M 9571 Y Y Y Y Non-Vegetarian
7 Balasundari 18 F 10147 Y Y Y Y Y Y Non-Vegetarian
8 Mariammal 33 F 10333 Y Y Y Y Y Y Non-Vegetarian
9 Pushpa 30 F 11385 Y Y Y Y Y Y Non-Vegetarian
10 Saraswathi 56 F 42276 Y Y Y Non-Vegetarian
11 Palaniammal 21 F 12543 Y Y Y Y Y Y Y Non-Vegetarian
12 Marisamy 19 M 14400 Y Y Y Y Non-Vegetarian
13 Sally 19 M 14659 Y Y Y Y Non-Vegetarian
14 Arumugathai 45 F 15128 Y Y Y Y Y Y Non-Vegetarian
15 Esakkiammal 25 F 15365 Y Y Y Non-Vegetarian
16 Jaya Ganesh 17 M 12583 Y Y Y Y Y Non-Vegetarian
17 Samidurai 40 M 45729 Y Y Y Y Non-Vegetarian
18 Subharangitha 20 F 46267 Y Y Y Y Non-Vegetarian
19 Vijayalakshmi 47 F 48284 Y Y Y Y Y Non-Vegetarian
20 Parvati 70 F 47507 Y Y Y Y Vegetarian
21 Shekhar 38 M 24122 Y Y Y Y Y Non-Vegetarian
22 Arumugakani 22 F 26983 Y Y Y Y Y Y Y Non-Vegetarian
23 Chellammal 75 F 26313 Y Y Y Y Vegetarian
24 Mariammal 42 F 26711 Y Y Y Y Y Y Non-Vegetarian
25 Chellammal 30 F 26752 Y Y Y Y Y Y Non-Vegetarian
26 Shanmugam 86 M 26861 Y Y Y Y Y Y Y Y Y Non-Vegetarian
27 Sita Lakshmi 29 F 26964 Y Y Y Non-Vegetarian
28 Vasuki 27 F 26773 Y Y Y Y Non-Vegetarian
29 Subbuthai 47 F 27312 Y Y Y Y Non-Vegetarian
30 Mallika 50 F 27565 Y Y Y Y Y Non-Vegetarian
31 Thilakavathy 17 F 27962 Y Y Y Y Non-Vegetarian
32 Priyanka 17 F 30352 Y Y Y Vegetarian
33 Indira 17 F 28574 Y Y Y Y Y Y Y Vegetarian
34 Mariya Yovan 18 M 28234 Y Y Y Y Y Non-Vegetarian
35 Mariya Jose 32 M 43255 Y Y Y Y Non-Vegetarian
36 Karuppusamy 33 M 30414 Y Y Y Non-Vegetarian
37 Vasantha 59 F 43065 Y Y Y Y Y Vegetarian
38 Hameeda Banu 28 F 30689 Y Y Y Y Non-Vegetarian
39 Krishnaveni 23 F 31542 Y Y Y Y Y Non-Vegetarian
40 Selvi 30 F 34790 Y Y Y Y Y Non-Vegetarian
41 Parvati 44 F 31673 Y Y Y Y Y Y Non-Vegetarian
42 Mariyatholan 55 M 35145 Y Y Y Y Y Non-Vegetarian
43 Anthony 64 M 35986 Y Y Y Y Y Y Non-Vegetarian
44 Thirumeni 24 M 42675 Y Y Y Y Y Y Vegetarian
45 Nilavati 70 F 44721 Y Y Y Y Y Non-Vegetarian
46 Tamilselven 30 M 44844 Y Y Y Y Y Non-Vegetarian
47 Subramanian 52 M 36152 Y Y Y Y Y Y Vegetarian
48 Ramasubbu 30 M 36760 Y Y Y Non-Vegetarian
49 Parajyothy 50 F 44671 Y Y Y Y Y Non-Vegetarian
50 Subramani 58 M 33715 Y Y Y Y Non-Vegetarian
51 Malathi 32 F 38305 Y Y Y Y Non-Vegetarian
52 Leelavati 68 F 38386 Y Y Y Y Y Y Y Non-Vegetarian
53 Suresh Kumar 13 M 39076 Y Y Y Y Y Y Y Non-Vegetarian
54 Sivaramakrishnan 14 M 39497 Y Y Y Y Y Non-Vegetarian
55 Muppidathy 45 F 53627 Y Y Y Y Y Y Y Non-Vegetarian
56 Kanakammal 25 F 41979 Y Y Y Y Y Vegetarian
57 Gandhimati 28 F 39996 Y Y Y Y Y Y Y Y Non-Vegetarian
58 Moothammal 61 F 54053 Y Y Y Y Y Y Non-Vegetarian
59 Murugan 48 M 54498 Y Y Y Y Non-Vegetarian
60 Muhammed Sahib 48 M 54118 Y Y Y Y Non-Vegetarian
NAMESL NO
PRESENTING COMPLAINTS PAST HISTORY PERSONAL HISTORY
IP NoSEXAGE DIET HISTORY
Pallor Icterus
Lymphad
eno-pathy
Oedema
Hepato-
megaly
Spleno-
megaly
Both
Hemoglob
in
RBC 
Count
Total 
Count
Differenti
al Count
Platelet MCV MCH MCHC PCV ESR RFT LFT
Peripheral 
Smear
Bone Marrow
Y 9.7 4.38 2200 Normal 60000 87 26 30 38 80 Normal Normal Dimorphic Splenomegaly Infection
Y Y 3.9 1.28 3200 Normal 33000 90 29.4 32.7 11.7 150 Normal Normal Dimorphic Normal Chronic Kidney Disease
Y Y Y 3.1 0.9 2300 Lymphocytosis 27000 102 34 33 9.2 67 Abnormal Abnormal Macrocytic Normal Drug Induced
Y Y 6.9 1.82 2200 Normal 23000 122.8 42.6 34.7 19.3 26 Normal Abnormal Macrocytic Splenomegaly Megaloblastic Anemia
Y 3.6 1.73 2200 Neutrophilia 35000 67 26 30 62.3 150 Normal Normal Microcytic Splenomegaly Hypersplenism/DCLD
Y Y 2.4 0.7 1600 Lymphocytosis 6000 68 24 30 7.3 73 Abnormal Normal Microcytic Medico Renal Disease Chronic Kidney Disease
Y 4.4 2.19 3300 Normal 7000 76.2 21.8 28.6 17.3 64 Normal Normal Microcytic Normal Infection
Y Y Y 4.5 2.17 3700 Normal 56000 76.4 29.4 30.8 16.9 100 Normal Normal Dimorphic Splenomegaly Hypersplenism/DCLD
Y Y 5 1.54 3500 Lymphocytosis 33000 102 33.1 32.5 15.3 74 Normal Normal Dimorphic Splenomegaly Hypersplenism/DCLD
Y 7 2.42 1000 Neutrophilia 50000 87.7 25.8 32.9 21.3 94 Normal Normal Normocytic Parenchymal Liver Disease
Combined Nutritional 
Deficiency
Y Y Y 3 0.86 2100 Normal 78000 115.1 34.9 30.3 9.9 145 Normal Abnormal Macrocytic Splenomegaly Hypersplenism/DCLD
Y 6 1.7 3900 Lymphocytosis 19000 104 34.7 33.3 18 50 Normal Abnormal Dimorphic Dimorphic Anaemia Normal Dimorphic Anaemia
Y 8.1 2.5 2600 Neutrophilia 53000 98.4 32.4 32.9 24.6 50 Normal Abnormal Dimorphic Splenomegaly Infection
Y 6.5 2.05 2200 Normal 61000 95.6 31.7 33.2 19.6 48 Normal Normal Dimorphic Normal Dimorphic Anaemia
Y Y 8.3 2.5 2000 Normal 60000 95.3 32.7 34.3 24.2 42 Normal Normal Dimorphic Normal Dimorphic Anaemia
Y 9.2 4.53 2500 Lymphocytosis 71000 84 28 32.4 32.7 28 Normal Normal Normocytic Normal Chronic Disease
Y 8.1 3 2500 Normal 37000 86 27 31 25.8 32 Normal Normal Microcytic
Combined Nutritional 
Deficiency
Splenomegaly
Combined Nutritional 
Deficiency
Y Y 3.4 1.76 1200 Lymphocytosis 27000 72 22 28 10.5 82 Normal Normal Microcytic Aplastic Anaemia Normal Aplastic Anaemia
Y Y Y Y 4.4 2.77 1300 Normal 14000 60 15 26 16.7 73 Normal Abnormal Microcytic Parenchymal Liver Disease Hypersplenism/DCLD
Y Y 5.6 2.79 2700 Normal 64000 72 20 27 20.1 64 Normal Normal Microcytic Parenchymal Liver Disease Hypersplenism/DCLD
Y Y 5.9 1.89 1400 Lymphocytosis 20000 89.9 31.2 34.7 17 84 Normal Normal Normocytic
Acute Lymphocytic 
Leukemia
Normal
Acute Lymphocytic 
Leukemia
Y Y Y Y 3.6 1.53 3600 Normal 80000 88.9 23.5 26.5 13.6 50 Abnormal Abnormal Dimorphic Splenomegaly Sepsis
Y Y 2.3 1.23 1400 Neutrophilia 39000 64.3 24 28 9 82 Abnormal Normal Microcytic Aplastic Anaemia Normal Aplastic Anaemia
Y Y Y 3.8 2.37 2300 Normal 96000 64.6 16 24.8 15.3 70 Normal Normal Microcytic Normal Dimorphic Anaemia
Y Y 4.4 1.72 3700 Neutrophilia 9000 78.5 25.6 32.6 13.5 62 Normal Normal Normocytic Normal Sepsis
Y Y 3.9 1.02 2200 Lymphocytosis 38000 118.6 38.2 32.3 12.1 55 Normal Normal Dimorphic Normal Dimorphic Anaemia
Y Y Y Y 9 3.24 1700 Neutrophilia 33000 76.3 22.7 29.8 32 20 Normal Normal Microcytic Parenchymal Liver Disease Hypersplenism/DCLD
Y Y Y 6.8 2.3 2100 Neutrophilia 13000 88.3 29.6 33.5 20.3 72 Normal Abnormal Dimorphic Splenomegaly Sepsis
Y Y Y Y 9 4.2 1700 Normal 60000 82.1 22.4 27.3 33 125 Normal Normal Dimorphic Parenchymal Liver Disease Hypersplenism/DCLD
Y Y 7.1 1.97 2400 Lymphocytosis 14000 104.1 36 34.6 20.5 110 Normal Normal Dimorphic Normal Dimorphic Anaemia
Y Y Y 4.9 1.6 3000 Normal 21000 90.6 30.6 33.8 14.5 46 Normal Abnormal Dimorphic Normal Dimorphic Anaemia
Y Y 5.4 1.4 2800 Lymphocytosis 24000 118 38.6 37 14.6 60 Normal Abnormal Dimorphic Splenomegaly Vitamin B12 Deficiency
Y Y Y Y 5.2 1.46 1900 Lymphocytosis 13000 102.1 35.6 34.9 14.9 28 Normal Abnormal Dimorphic Hepatomegaly Megaloblastic Anemia
Y Y 9.3 3.36 2900 Normal 28000 79.2 27.7 35 26.6 48 Normal Normal Microcytic Splenomegaly Infection
Y 9.3 3.21 600 Neutrophilia 53000 80 26 29 26.1 150 Abnormal Normal Microcytic Aplastic Anaemia Normal Aplastic Anaemia
Y Y Y 7.5 2.27 1700 Lymphocytosis 92000 88.1 33 37.5 20 36 Normal Abnormal Dimorphic Normal Vitamin B12 Deficiency
Y Y 6.7 2.25 3600 Normal 43000 94.7 29.8 31.5 28 155 Abnormal Abnormal Macrocytic Hepatomegaly Drug Induced
Y Y Y 3.9 2.56 2600 Normal 43000 56.6 15.2 26.9 14.5 10 Normal Normal Microcytic Splenomegaly Myelofibrosis
Y 5.8 2.14 2800 Normal 49000 85 27.1 31.9 18.2 24 Abnormal Normal Dimorphic Medico Renal Disease Drug Induced
Y 8.4 3.63 3900 Neutrophilia 60000 76.9 23.1 30.1 27.9 51 Abnormal Normal Dimorphic Normal Sepsis
Y Y Y Y 5 2.51 1400 Neutrophilia 14000 70.1 19.9 28.4 17.6 44 Normal Abnormal Microcytic Splenomegaly Hypersplenism/DCLD
Y Y Y Y 3.8 1.45 2300 Normal 52000 81.4 26.2 32.2 11.8 27 Normal Normal Dimorphic Splenomegaly Hypersplenism/DCLD
Y Y Y Y 8.1 2.49 2100 Neutrophilia 25000 92 27 33 22.3 44 Normal Abnormal Normocytic Myelofibrosis Hepatomegaly Myelofibrosis
Y Y 5.8 1.63 2900 Lymphocytosis 58000 104 30 37 17.2 49 Normal Normal Macrocytic Hepatosplenomegaly Vitamin B12 Deficiency
Y Y 3.5 1.01 3700 Lymphocytosis 3000 100 35 35 10 62 Abnormal Normal Dimorphic Normal Megaloblastic Anemia
Y 6.1 1.87 3300 Lymphocytosis 8000 93.6 32.6 34.9 17.8 62 Normal Normal Macrocytic Normal Infection
Y Y Y 2.5 1.07 3100 Lymphocytosis 26000 108.7 36.2 33.3 7.5 84 Normal Normal Macrocytic Hepatomegaly Vitamin B12 Deficiency
9.9 4.02 2500 Neutrophilia 55000 73.4 24.6 33.6 29.5 5 Normal Normal Microcytic Hepatomegaly Infection
Y Y 2.8 0.68 1400 Lymphocytosis 18000 129.4 41.2 31.8 8.8 72 Normal Normal Dimorphic Normal Megaloblastic Anemia
Y Y Y 5.1 2.97 2000 Normal 76000 65.3 17.2 26.3 19.4 70 Abnormal Normal Microcytic Hepatosplenomegaly Hypersplenism/DCLD
Y Y 7.5 2.48 2600 Normal 40000 84.3 30.2 35.9 20.9 75 Normal Abnormal Microcytic Normal Chronic disease
Y 6.6 2.05 2600 Lymphocytosis 6000 92.2 32.2 34.9 18.9 125 Normal Normal Dimorphic Parenchymal Liver Disease Hypersplenism/DCLD
Y Y Y 4.8 1.68 2000 Lymphocytosis 25000 84.5 28.6 33.8 14.2 15 Normal Abnormal Dimorphic Splenomegaly
Combined Nutritional 
Deficiency
Y 9.9 4.03 3500 Normal 76000 71.1 24.8 34.8 28.7 50 Normal Normal Microcytic
Combined Nutritional 
Deficiency
Normal
Combined Nutritional 
Deficiency
Y Y Y Y 6.2 2.94 1200 Normal 41000 72 20 28 21 70 Normal Abnormal Dimorphic
Haemophagocytic 
Lymphohistiocytosis
Hepatosplenomegaly Dimorphic Anaemia
Y 6 1.89 2300 Normal 42000 103.2 31.7 30.8 22 50 Normal Abnormal Dimorphic
Micronormoblastic 
Erythropoiesis
Splenomegaly Vitamin B12 Deficiency
Y Y Y 5.4 1.77 2700 Neutrophilia 58000 92.1 30.5 33.1 16.3 70 Normal Normal Dimorphic Splenomegaly Dimorphic Anaemia
Y Y 3.3 1.83 2000 Normal 76000 64 17 26 13.5 50 Normal Normal Microcytic Parenchymal Liver Disease Hypersplenism/DCLD
Y Y Y 4 0.95 2100 Lymphocytosis 7000 123.2 42 34.2 11.7 48 Normal Abnormal Macrocytic Normal Vitamin B12 Deficiency
Y Y Y Y 2.7 1.5 3700 Normal 97000 59 18 31 8.6 30 Abnormal Normal Microcytic Hepatosplenomegaly Hypersplenism/DCLD
LAB PATHOLOGYGENERAL EXAMINATION SYSTEMIC EXAMINATION
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